The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.
Saved in:
| Title: | The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy. |
|---|---|
| Authors: | Fujita, Kazutoshi1 (AUTHOR) kazufujita2@gmail.com, Matsushita, Yuto2 (AUTHOR), Toyoda, Shingo1 (AUTHOR), Kojima, Takahiro3 (AUTHOR), Yamashita, Shimpei4 (AUTHOR), Taniguchi, Hisanori5 (AUTHOR), Monji, Keisuke6 (AUTHOR), Ishiyama, Ryo7 (AUTHOR), Tatarano, Shuichi8 (AUTHOR), Masui, Kimihiko9 (AUTHOR), Nakamura, Eijiro10 (AUTHOR), Kaneko, Tomoyuki11 (AUTHOR), Kitano, Goshi3 (AUTHOR), Motoshima, Takanobu12 (AUTHOR), Shiraishi13 (AUTHOR), Kira, Satoru14 (AUTHOR), Murashima, Takaya15 (AUTHOR), Hara, Hiroaki16 (AUTHOR), Matsumura17 (AUTHOR), Nishiyama, Naotaka18 (AUTHOR) |
| Source: | World Journal of Urology. 9/26/2024, Vol. 42 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
